These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 11151656)

  • 1. [Psychosocial consequences of screening for microalbuminuria and for some other risk factors].
    Tijmstra T; Spijkers W; Broer J; Janssen WM; de Jong PE
    Ned Tijdschr Geneeskd; 2000 Dec; 144(51):2460-4. PubMed ID: 11151656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial consequences of screening for albuminuria and certain other risk factors.
    Tymstra T; Spijkers EW; Broer J; Janssen WM; de Jong PE
    Int J Risk Saf Med; 2001; 14(1):51-7. PubMed ID: 22388485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT).
    Atthobari J; Asselbergs FW; Boersma C; de Vries R; Hillege HL; van Gilst WH; Gansevoort RT; de Jong PE; de Jong-van den Berg LT; Postma MJ;
    Clin Ther; 2006 Mar; 28(3):432-44. PubMed ID: 16750458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing vascular risk in hypertension with a focus on microalbuminuria: attitude and practices.
    Wu AY; Low LP
    Singapore Med J; 2009 Oct; 50(10):976-81. PubMed ID: 19907888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can cancer risk information raise awareness without increasing anxiety? A randomized trial.
    Robb KA; Miles A; Campbell J; Evans P; Wardle J
    Prev Med; 2006 Sep; 43(3):187-90. PubMed ID: 16765428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of elevated cardiovascular risk detected by screening. A qualitative interview study.
    Bach Nielsen KD; Dyhr L; Lauritzen T; Malterud K
    Scand J Prim Health Care; 2005 Dec; 23(4):233-8. PubMed ID: 16272072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dental screening and referral of young children by pediatric primary care providers.
    dela Cruz GG; Rozier RG; Slade G
    Pediatrics; 2004 Nov; 114(5):e642-52. PubMed ID: 15520094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Can systematic general health screening and patient-physician health discussions improve the cardiovascular profile of the population? A randomized controlled trial in general practice with a 5-year follow-up].
    Engberg M; Christensen B; Karlsmose B; Lous J; Lauritzen T
    Ugeskr Laeger; 2002 Jun; 164(25):3354-60. PubMed ID: 12107951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
    Kalaitzidis R; Li S; Wang C; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S22-31. PubMed ID: 19285608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening.
    Halbesma N; Kuiken DS; Brantsma AH; Bakker SJ; Wetzels JF; De Zeeuw D; De Jong PE; Gansevoort RT
    J Am Soc Nephrol; 2006 Sep; 17(9):2582-90. PubMed ID: 16899519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for major cardiovascular risk factors among Members of Polish Parliament as a continuation of health marketing for effective cardiovascular prevention in Poland. Warsaw, May 2006.
    Rutkowski M; Zdrojewski T; Bandosz P; Wierucki L; Piwoński J; Piwońska A; Narkiewicz K; Opolski G; Drygas W; Korewicki J; Wyrzykowski B
    Kardiol Pol; 2007 May; 65(5):486-92; discussion 493-4. PubMed ID: 17577845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microalbuminuria in treated hypertensives: only a mirror image of cardiovascular risk? The HUNT Study, Norway.
    Kvenild K; Romundstad S; Midthjell K; Krüger O; Hallan H; Holmen J
    Scand J Prim Health Care; 2006 Sep; 24(3):145-53. PubMed ID: 16923623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Dutch National Colesterol Test: participants mainly healthy].
    Deutekom M; Aziz Y; van Dis I; Stronks K; Bossuyt PM
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2425-9. PubMed ID: 19055144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention and screening of chronic renal failure].
    Bourel M; Ardaillou R
    Bull Acad Natl Med; 2004; 188(8):1455-68. PubMed ID: 15918671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular secondary prevention: patients' knowledge of cardiovascular risk factors and their attitude to reduce the risk burden, and the practice of family doctors. The "Help Your Heart Stay Young" study.
    Celentano A; Palmieri V; Arezzi E; Sabatella M; Guillaro B; Brancati C; Piccinocchi G; Minichiello S; Russo C; Pezzullo S; Tufano A; Finelli L; Panico S; Di Minno G
    Ital Heart J; 2004 Oct; 5(10):767-73. PubMed ID: 15626274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Material, psychosocial, and behavioural factors in the explanation of educational inequalities in mortality in The Netherlands.
    van Oort FV; van Lenthe FJ; Mackenbach JP
    J Epidemiol Community Health; 2005 Mar; 59(3):214-20. PubMed ID: 15710599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education.
    Baay MF; Verhoeven V; Peremans L; Avonts D; Vermorken JB
    Patient Educ Couns; 2006 Aug; 62(2):277-81. PubMed ID: 16533588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.